Minimal Phenotyping Yields Genome-Wide Association Signals of Low Specificity for Major Depression
View/ Open
Text (245.2Kb)
figure (50.56Kb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Cai, Na
Revez, Joana A.
Adams, Mark J.
Andlauer, Till F. M.
Breen, Gerome
Byrne, Enda M.
Clarke, Toni-Kim
Forstner, Andreas J.
Grabe, Hans J.
Hamilton, Steven P.
Levinson, Douglas F.
Lewis, Cathryn M.
Lewis, Glyn
Martin, Nicholas G.
Milaneschi, Yuri
Mors, Ole
Muller-Myhsok, Bertram
Penninx, Brenda W. J. H.
Perlis, Roy H.
Pistis, Giorgio
Potash, James B.
Preisig, Martin
Shi, Jianxin
Smoller, Jordan W.
Streit, Fabien
Uher, Rudolf
Van der Auwera, Sandra
Viktorin, Alexander
Weissman, Myrna M.
Kendler, Kenneth S.
Flint, Jonathan
Metadata
Show full item recordCitation
Cai, Na, Revez, Joana A, Adams, Mark J, Andlauer, Till F. M, Breen, Gerome, Byrne, Enda M, Clarke, Toni-Kim, Forstner, Andreas J, Grabe, Hans J, Hamilton, Steven P, Levinson, Douglas F, Lewis, Cathryn M, Lewis, Glyn, Martin, Nicholas G, Milaneschi, Yuri, Mors, Ole, Mueller-Myhsok, Bertram, Penninx, Brenda W. J. H, Perlis, Roy H, Pistis, Giorgio, Potash, James B, Preisig, Martin, Shi, Jianxin, Smoller, Jordan W, Streit, Fabien, Tiemeier, Henning, Uher, Rudolf, Van Der Auwera, Sandra, Viktorin, Alexander, Weissman, Myrna M, Kendler, Kenneth S, and Flint, Jonathan. "Minimal Phenotyping Yields Genome-wide Association Signals of Low Specificity for Major Depression." Nature Genetics 52, no. 4 (2020): 437-47.Abstract
Minimal phenotyping refers to the reliance on the use of a small number of self-report items for disease case identification, increasingly used in genome-wide association studies (GWAS). Here we report differences in genetic architecture between depression defined by minimal phenotyping and strictly defined Major Depressive Disorder (MDD): the former has a lower genotype-derived heritability that cannot be explained by inclusion of milder cases, and a higher proportion of the genome contributing to this shared genetic liability with other conditions than strictly-defined MDD. GWAS on minimal phenotyping definitions identify loci that are not specific to MDD, and though it can generate highly predictive polygenic risk scores, the predictive power can be explained entirely by large sample sizes rather than specificity for MDD. Our results reveal reliance on results from minimal phenotyping may bias our views of the genetic architecture of MDD and impede our ability to identify pathways specific to MDD.Citable link to this page
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37371856
Collections
- SPH Scholarly Articles [6329]
Contact administrator regarding this item (to report mistakes or request changes)